Image

Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)

Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

JDEPTH-LM Registry is a prospective, observational, multi-center study designed for the efficacy and safety of Double-effect kissing balloon technique (W-KBT) in left main (LM) bifurcation percutaneous coronary intervention (PCI) using Perfusion balloon (PB) and Drug coated balloon (DCB) in patients with left main coronary artery disease (LMD) with left circumflex artery (LCx) ostium stenosis.

Description

JDEPTH-LM Registry is a prospective observational multi-center study. The investigators will enroll and treat patients in the registry who meet the selection criteria under usual care and for whom PCI with W-KBT following on crossover stenting for LMT-LAD direction, proximal optimization technique (POT), and conventional kissing balloon technique (C-KBT) is the optimal treatment. The operators shall obtain oral or written consent from patients who meet the criteria before performing PCI, indicating the intention to perform PCI with W-KBT, and shall keep records. The investigators will continuously register cases attempting PCI with W-KBT according to the protocol and evaluate its efficacy and safety using data from this multi-center registry.

Eligibility

Inclusion Criteria:

  1. Age ≥ 18 years
  2. Patient with stable coronary artery disease, non-ST-elevation myocardial infarction, or unstable angina
  3. Left main disease confirmed by coronary angiography or coronary CT angiography
  4. Clinical and anatomical eligibility for PCI as agreed by the local Heart Team
  5. Patient with consent prior to undergoing PCI
  6. Left main Medina classification (1,1,1), (1,0,1), (0,1,1) confirmed by coronary angiography
  7. De novo target lesion in LMT-LAD amenable for crossover stenting with provisional side-branch approach as determined by PCI operator
  8. De novo ostial LCx lesions
  9. Lesion indicated in No. 8 with a length of less than 10 mm or a stenosis of less than 70% confirmed by coronary angiography

Exclusion Criteria:

  1. Inability to provide written informed consent
  2. Patient with a history of ST-elevation myocardial infarction within the previous 1 week
  3. Patient in a state of cardiogenic shock
  4. Patient with a history of coronary artery bypass grafting
  5. Patient with malignant tumors or other conditions with a life expectancy of less than one year
  6. Patient considered suitable for stent placement in the ostial LCx from a medical perspective
  7. Patient considered unsuitable for anti-thrombotic therapy after PCI
  8. Other patient whom the investigator deems unsuitable for the safe conduct of LM-PCI, including W-KBT

Study details
    Stable Angina
    Non-ST-elevation Acute Coronary Syndrome
    Unstable Angina

NCT06436092

TCROSS Co., Ltd.

8 June 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.